I have been holding that and adding on the drop last week, its about to begin a trip to the north.
Great results on their TH-302 drug so far.
REDWOOD CITY, Calif., April 4, 2011 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced multiple preclinical presentations on its clinical stage hypoxia-activated prodrug, TH-302, at the American Association for Cancer Research (AACR) Annual Meeting, being held April 2 to 6, 2011, in Orlando, FL.
"These are very exciting preclinical results which extend our understanding of the mechanism of action and antitumor activity of TH-302," said Charles Hart, Ph.D., Threshold's vice president of biology. "Our translational observations provide further support that TH-302 is selectively targeting tumor hypoxia. In particular, the results support the hypothesis that TH-302 may combine well clinically with antiangiogenic agents that have been shown to increase tumor hypoxia preclinically."
could be just the drug we need to help us concentrate on Royl.Could you pump Royl on the THLD board as a provider of energy for their pharmacy operations?Can they inprove efficiency by switching to Natural gas?Could THLD drugs help you from miscatagorizing different sectors?